“We are committed to helping shape the future of medicine by developing new therapeutics and providing powerful diagnostic and research reagents based on our Affimer platform.
At our Cambridge facility we are building a pipeline of next-generation Affimer cancer immuno-therapies to improve patients’ lives, and at our Wetherby site we are working closely with a wide range of life sciences customers to develop Affimer reagents for their product development pipelines.
There are many interesting opportunities in Avacta and it’s a work place where meeting those challenges is enjoyable and rewarding.
If you’re interested in a career at Avacta then it would be great to hear from you.”
Dr Alastair Smith, Chief Executive